Local-regional control by conventional radiotherapy according to tumor volume in patients with squamous cell carcinoma of the pharyngolarynx

Japanese Journal of Clinical Oncology

Volumn 29, Issue 10, 1999, Pages 467-473

  Kawashima, Mitsuhiko ^a   Ogino, Takashi ^a   Fujii, Hirofumi ^a   Ishikura, Satoshi ^a   Ito, Yoshinori ^a   Ikeda, Hiroshi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

Conventional fractionation; Head and neck cancer; Local regional control; Radiotherapy; Tumor volume

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LARYNX TUMOR; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PHARYNX CANCER; PROGNOSIS; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DOSE FRACTIONATION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PHARYNGEAL NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 0033202452     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.10.467     Document Type: Article

References (24)

1. Wang CC, Suit HD, Blitzer PH. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys 1986;12:3-7.
2. Fein DA, Mendenhall W, Parsons JT, Stringer SP, Cassisi NJ, Million RR. Pharyngeal wall carcinoma treated with radiotherapy: impact of treatment technique and fractionation. Int J Radiat Oncol Biol Phys 1993;26:751-7.
3. Mendenhall WM. T3-4 squamous cell carcinoma of the larynx treated with radiation therapy alone. Semin Radiat Oncol 1998;8:262-9.
4. Horiot JC, Le Fur R, N'Guyen T, Chenal C, Schraub S, Alfonsi S, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-41.
5. Pinto LH, Canary PC, Araujo CM, Bacelar SC, Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-62.
6. Horiot JC, Bontemps P, van den Bogaert W, Fur RL, van den Weijngaert D, Bolla M, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111.
7. Britzel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-804.
8. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study. J Clin Oncol 1998;16:1318-24.
9. Merlano M, Benasso M, Corvo R, Rosso R, Vitale V, Blengio F, et al. Five year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck. J Natl Cancer Inst 1996;88:583-9.
10. Dubben HH, Thames HD, Beck-Bornholdt HP. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 1998;47:167-74.
11. Grabenbauer GG, Steininger H, Meyer M, Fietkau R, Brunner T, Heinkelmann P, et al. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer. Radiother Oncol 1998;47:175-83.
12. Raaphorst GP, Ng CE, Bichay T. Further on prediction of radiotherapy response using SF2. Is it methodology or mythology? Radiother Oncol 1994;31:88-9.
13. Zackrisson B, Gustafsson H, Stenling R, Flygare P, Wilson GD. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int J Radiat Oncol Biol Phys 1997;38:677-83.
14. Koch WM, Brennan JA, Zahurak M, Goodman SN, Westra WH, Schwab D, et al. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996;88:1580-6.
15. Brenner DJ. Dose, volume and tumor-control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 1993;26:171-9.
16. Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys 1995;33:281-7.
17. Kaplan EL, Meier P. Non parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
18. Cox DR. Regression models and life-tables. J R Stat Soc 1972;34:187-220.
19. Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP, Cassisi NJ. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck 1996;18:24-35.
20. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ. T4 laryngeal carcinoma: radiotherapy alone with surgery reserved for salvage. Int J Radiat Oncol Biol Phys 1998;40:549-52.
21. Chua DTT, Sham JST, Kwong DLW, Tai KS, Wu PM, Sc MLB, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997;39:711-19.
22. Bentzen SM, Thames HD. Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys 1996;36:247-51.
23. Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumours, 5th ed. New York: Wiley 1997.
24. Perez CA, Patel MM, Chao KSC, Simpson JR, Sessions D, Spector GJ, et al. Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. Int J Radiat Oncol Biol Phys 1998;42:1077-84.